StonvexLoading…
StonvexStonvexStonvexCore line items from AXP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $10.52B | $41.30B | $30.36B | $19.95B |
Operating Income | $3.78B | $13.79B | $10.71B | $6.88B |
Net Income | $2.97B | $10.83B | $8.37B | $5.47B |
EPS (Diluted) | $4.28 | $15.38 | $11.85 | $7.71 |
Total Assets | $308.89B | $300.05B | $297.55B | $295.56B |
Total Liabilities | $274.90B | $266.58B | $265.13B | $263.25B |
Cash & Equivalents | $53.76B | $47.79B | $54.71B | $57.94B |
Free Cash Flow OCF − CapEx | $2.65B | $16.00B | $13.66B | $8.08B |
Shares Outstanding | 682.00M | 686.00M | 689.00M | 696.00M |